SCHEMBL7956469

SCHEMBL7956469

N#CSc1ccc(Cl)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
ALDH1A1 P00352 3/20 0.39
GABRA1 P14867 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA2 P47869 1/20 0.38
CA2 P00918 1/20 0.37
CA5A P35218 1/20 0.37
PIK3CD O00329 1/20 0.35
NAPRT Q6XQN6 1/20 0.35
POLB P06746 2/20 0.34
KDM4E B2RXH2 1/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ADRA2A P08913 2/20 0.33
ADRA2B P18089 2/20 0.33
ADRA2C P18825 2/20 0.33
MYC P01106 1/20 0.33
WDR5 P61964 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10280707 0.75 PIK3CD (0.41) MAPTPIK3CDNAPRTPOLBKDM4E
SCHEMBL29978927 0.71
SCHEMBL21288402 0.71
SCHEMBL1145839 0.71
SCHEMBL1145837 0.71
SCHEMBL4408306 0.71 ALDH1A1 (0.64) MAPTALDH1A1GABRA1GABRG2GABRB3
SCHEMBL6245448 0.70 MAPT (0.52) MAPTALDH1A1CA2CA5APOLB
SCHEMBL75830 0.67
SCHEMBL30212370 0.67
SCHEMBL23833573 0.67 SMN1; SMN2 (0.41) PIK3CDNAPRTPOLBADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed
EP-0880501-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
WO-1997028128-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1997-08-07 WO disclosed